First placebo-controlled trial in renal scleroderma shows positive results for zibotentan Nov. 19, 2019 No Comments
Sparsentan does not appear to have a negative effect on quality of life in FSGS patients Nov. 18, 2019 No Comments
Results from SILK cohort evaluating tesevatinib in ADPKD patients presented at Kidney Week Nov. 15, 2019 No Comments
Phase III portion of CARDINAL study of bardoxolone in Alport syndrome meets primary endpoint Nov. 12, 2019 No Comments
Heterozygous COL4A1 mutations are a potential autosomal dominant cause of CAKUT Oct. 25, 2019 No Comments
RSS